Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Pediatr Transplant. 2011 Aug 23;15(7):733–741. doi: 10.1111/j.1399-3046.2011.01563.x

Table 4. Immunological reconstitution in the 7 surviving T-B+NK+ SCID patients after HCT.

Patient Lymphocyte Absolute Counts (per μL) CD3 Absolute Count (per μL) CD4 Absolute Count (per μL) CD8 Absolute Count (per μL) CD19 Absolute Count (per μL) CD16/56 Absolute Count (per μL) IgG (mg/dL) IgA (mg/dL) IgM (mg/dL) PHA (%)
1a 704 169 120 99 338 ND 1130 87 90 9%
Post boost: 1200 1071 452 621 355 127 1020 151 122 90%
1b 1976 439 178 277 1344 68 1060 123 66 90%
3 2680 1876 938 911 429 214 1220 88 168 100%
4b Post BMT: 2300 <23 <23 <23 2070 207 n.a. n.a. n.a. 1%
Post boost: 1000 370 270 70 190 420 1100 183 91.3 100%
5a Post BMT: 750 195 120 75 248 262 1050 54.1 80.4 1%
Post Boost: 1370 1445 673 693 218 297 n.a. 27.5 69 100%
5b 1700 888 273 546 512 256 658 60 211 35%
6 2330 1701 862 629 468 140 n.a. 35 278 64%

Abbreviations: PHA = proliferation in response to phytohemagglutin (% of control value), n.a. = not available